CONMED Corporation
CNMD
$50.41
$0.591.18%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 66.84% | -17.39% | 485.48% | -86.65% | 254.89% |
| Total Depreciation and Amortization | 1.11% | 6.73% | -5.14% | 0.19% | 1.74% |
| Total Amortization of Deferred Charges | -17.40% | -53.41% | 114.66% | -8.07% | -3.81% |
| Total Other Non-Cash Items | 32.01% | -84.77% | 162.46% | 86.62% | -66.04% |
| Change in Net Operating Assets | 54.14% | -51.73% | -175.12% | 222.61% | -2,835.38% |
| Cash from Operations | 175.35% | -70.92% | -13.69% | 84.27% | -29.86% |
| Capital Expenditure | -1.45% | 43.42% | 1.47% | 9.46% | -51.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 107.14% | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | 181.55% | 157.77% | -37.09% | 9.46% | -95.60% |
| Total Debt Issued | 380.56% | -3.74% | 11.98% | -16.78% | 20.88% |
| Total Debt Repaid | -470.44% | 25.12% | -5.61% | 7.40% | -17.21% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 83.24% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -0.03% | -0.05% | -0.10% |
| Other Financing Activities | -97.93% | 5.75% | -34.11% | 10.77% | -22.44% |
| Cash from Financing | -105.00% | 39.65% | 14.14% | -64.08% | 6.59% |
| Foreign Exchange rate Adjustments | 84.15% | -2,494.12% | 70.00% | -98.73% | 91.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 139.71% | -406.51% | -62.19% | 422.19% | -114.06% |